Literature DB >> 14767278

Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension.

Yoshio Naya1, Joel W Slaton, Patricia Troncoso, Koji Okihara, R Joseph Babaian.   

Abstract

PURPOSE: We studied preoperative variables in a contemporary series of men who underwent nonnerve sparing radical prostatectomy in an effort to establish criteria that would predict side specific extraprostatic extension (EPE) of cancer.
MATERIALS AND METHODS: We reviewed the records of 430 patients who underwent radical prostatectomy for localized prostate cancer with no prior therapy between 1996 and 1998, and for whom we had at least sextant biopsy information. We evaluated biopsy data (Gleason score, maximum length of cancer in positive cores, percent of cancer per involved core, proportion of positive biopsy cores, tumor location and number of positive biopsy cores) and correlated these findings with EPE at the neurovascular bundle and posterior lateral (NVB/PL) region.
RESULTS: We found that a higher number of positive cores, a higher biopsy Gleason score on a side, a positive core at the basal region, 50% or greater tumor in the core or a maximum tumor length of 7 mm or greater increased the likelihood that EPE was present at the NVB/PL region on the corresponding side of the prostate. On multivariate analysis maximum tumor length 7 mm or greater and positive basal core location were the strongest independent predictors of EPE at the NVB/PL region on a given side (p <0.0001 and 0.002, respectively).
CONCLUSIONS: Excluding any patient with 1 positive biopsy core with a maximum tumor length of 7 mm or greater plus a positive basal core of any tumor length and grade can decrease the risk of EPE at the NVB/PL region to approximately 10%.

Entities:  

Mesh:

Year:  2004        PMID: 14767278     DOI: 10.1097/01.ju.0000103929.91486.29

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

2.  Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

Authors:  Stephen B Williams; Simpa Salami; Meredith M Regan; Donna P Ankerst; John T Wei; Mark A Rubin; Ian M Thompson; Martin G Sanda
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

Review 3.  [Diagnostic of prostate cancer: conventional and molecular or cell biological methods].

Authors:  M Susani; L Kenner; Z Culig
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

4.  Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?

Authors:  Maisa M Q Quintal; Luciana R Meirelles; Leandro L L Freitas; Luis A Magna; Ubirajara Ferreira; Athanase Billis
Journal:  Int Urol Nephrol       Date:  2011-02-22       Impact factor: 2.370

5.  Preoperative Predictors of Extraprostatic Extension of Prostate Cancer (pT3a) in a Contemporary Indian Cohort.

Authors:  Sohrab Arora; Gagan Gautam; Rakesh Khera; Rajesh K Ahlawat
Journal:  Indian J Surg Oncol       Date:  2017-06-17

6.  Preoperative nomograms for predicting extracapsular extension in Korean men with localized prostate cancer: a multi-institutional clinicopathologic study.

Authors:  Jae Seung Chung; Han Yong Choi; Hae-Ryoung Song; Seok-Soo Byun; Seong il Seo; Cheryn Song; Jin Seon Cho; Sang Eun Lee; Hanjong Ahn; Eun Sik Lee; Won-Jae Kim; Moon Kee Chung; Tae Young Jung; Ho Song Yu; Young Deuk Choi
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

Review 7.  Considerations for patient selection for focal therapy.

Authors:  John F Ward; Louis L Pisters
Journal:  Ther Adv Urol       Date:  2013-12

8.  Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.

Authors:  Daniel W Lin; Lisa F Newcomb; Elissa C Brown; James D Brooks; Peter R Carroll; Ziding Feng; Martin E Gleave; Raymond S Lance; Martin G Sanda; Ian M Thompson; John T Wei; Peter S Nelson
Journal:  Clin Cancer Res       Date:  2013-03-20       Impact factor: 12.531

9.  pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies.

Authors:  Sung Jin Kim; Chang Myon Park; Ki Taek Seong; Sea Young Kim; Han Kwon Kim; Jong Yeon Park
Journal:  Korean J Urol       Date:  2011-09-28

10.  Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml.

Authors:  Jin-Seok Chang; Hoon Choi; Young-Seop Chang; Jin-Bum Kim; Mi Mi Oh; Du Geon Moon; Jae Hyun Bae; Jun Cheon
Journal:  Korean J Urol       Date:  2011-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.